Trade Regeneron Pharmaceuticals, Inc. - REGN CFD

Trading Conditions

• Type: CFD
• Spread: 6.09
• Long position overnight funding adjustment: -0.02157%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 0.01
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 746.76
• Open: 745.65
• 1-Year Change: 8.39%
• Day's Range: 740.51 - 754.95

What is Regeneron Pharmaceuticals, Inc. (REGN)?

Regeneron Pharmaceuticals, Inc. is a biotechnology company engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company focuses on areas such as ophthalmology, oncology, immunology, and infectious diseases. It utilizes proprietary technologies to develop therapeutic antibodies and other biologics. Regeneron operates research and manufacturing facilities and collaborates with academic institutions and other companies to advance drug development. Its portfolio includes several approved products and a pipeline of investigational therapies. The company is headquartered in Tarrytown, New York.

Regeneron Pharmaceuticals, Inc. Stock Price Today: Live Overview

The price today is shaped by trading flows as Regeneron Pharmaceuticals, Inc. trades at $746.60. The intraday price has moved from $739.95 to $756.13, with a daily change of 0%.

FAQ: Regeneron Pharmaceuticals, Inc. (REGN)

What is the current price of REGN stock?

Regeneron Pharmaceuticals, Inc.'s stock price is $746.60.

Does REGN pay dividends?

Regeneron Pharmaceuticals, Inc. does not pay dividends.

Does REGN have a formal corporate presence or regional headquarters in the UAE?

Regeneron Pharmaceuticals, Inc. operates in the UAE via partnerships without a direct office.

What is REGN best known for?

The company is most famous for its development of innovative biopharmaceutical products.

What assets are typically shown together with REGN?

Commonly shown alongside REGN: Innovator Equity Defined Protection ETF - 2 Yr to July 2025, ADMA Biologics, Inc., Soligenix, Inc.